title: Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis.
authors.affiliation: North Carolina Clinical Research, Raleigh, North Carolina 27607, USA. claforce@nccr.com
authors.forename: Craig F
authors.initials: CF
authors.lastname: LaForce
authors.forename: Warner
authors.initials: W
authors.lastname: Carr
authors.forename: Stephen A
authors.initials: SA
authors.lastname: Tilles
authors.forename: Bradley E
authors.initials: BE
authors.lastname: Chipps
authors.forename: William
authors.initials: W
authors.lastname: Storms
authors.forename: Eli O
authors.initials: EO
authors.lastname: Meltzer
authors.forename: Michael
authors.initials: M
authors.lastname: Edwards
mesh_terms: D000281:Administration, Intranasal; D000328:Adult; D000730:Androstadienes / Q000008:administration & dosage* / Q000009:adverse effects; D003990:Dibenzoxepins / Q000008:administration & dosage* / Q000009:adverse effects; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D000068298:Fluticasone; D006633:Histamine Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008875:Middle Aged; D000069605:Olopatadine Hydrochloride; D010793:Phthalazines / Q000008:administration & dosage* / Q000009:adverse effects; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome; D014456:Ulcer / Q000209:etiology; D014987:Xerostomia / Q000209:etiology
chemical_list: D000730:Androstadienes; D003990:Dibenzoxepins; D006633:Histamine Antagonists; D010793:Phthalazines; D000069605:Olopatadine Hydrochloride; D000068298:Fluticasone; C020976:azelastine